# MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

> **NCT00252174** · PHASE2 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 2 (actual)

## Conditions studied

- Anxiety Disorder
- Cancer

## Interventions

- **DRUG:** Stage 1 Active Methylenedioxymethamphetamine
- **DRUG:** Stage 1 Low dose Methylenedioxymethamphetamine
- **BEHAVIORAL:** Psychotherapy
- **DRUG:** Stage 2 Active Methylenedioxymethamphetamine

## Key facts

- **NCT ID:** NCT00252174
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2010-12
- **Final completion:** 2011-03
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of funds and insufficient patient population for study enrollment.
- **Last updated:** 2017-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252174, "MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00252174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*